MCHX, US56624R1086

Marchex Inc stock (US56624R1086): investors eye merger vote and legal review as shares hover around USD 1.60

Veröffentlicht: 03.06.2026 um 05:22 Uhr, Redaktion AD HOC NEWS, Redaktionelle Verantwortung: Rafael Müller (Chefredaktion)

Marchex shares on Nasdaq remain near USD 1.60 as investors in the United States watch the pending merger with Archenia and note a fresh shareholder-rights investigation announced this week.

MCHX, US56624R1086
MCHX, US56624R1086

Marchex stock was little changed in the United States on 06/02/2026, with the Nasdaq-listed shares closing at USD 1.64 after slipping USD 0.01 in late trading, while investors focus on the company’s pending merger with Archenia and related shareholder litigation developments, according to a report from New York on that date.

The stock, which trades on Nasdaq under the symbol MCHX, is drawing attention from U.S. retail holders ahead of a shareholder vote on the Archenia transaction, with some law firms publicizing investigations into whether the agreed terms adequately protect minority investors.GlobeNewswire as of 06/02/2026

The shares traded at USD 1.64 on 06/02/2026 on Nasdaq, according to closing data cited in a New York market commentary that day.

As of: 06/03/2026

By the editorial team - specialized in equity coverage.

At a glance

  • Name: Marchex Inc
  • Sector/industry: Marketing technology and customer analytics
  • Headquarters/country: Seattle, United States
  • Core markets: North America, with a focus on U.S. enterprise and mid-market clients
  • Key revenue drivers: Conversation analytics, call tracking and related software solutions for marketing and customer engagement teams
  • Home exchange/listing venue: Nasdaq (MCHX)
  • Trading currency: USD

Marchex Inc: core business model

Marchex centers its business on software and data tools that help enterprises analyze and optimize customer conversations, generating revenue primarily from subscription and usage-based fees tied to its analytics and call-tracking platforms.

Marchex Inc in peer comparison

In the customer-engagement and marketing-technology space, Marchex competes with specialists such as LivePerson and The Trade Desk, although the peers differ in product focus and market positioning. LivePerson, a Nasdaq-listed provider of conversational commerce solutions, closed at USD 2.27 on 05/29/2026, highlighting how investor sentiment in adjacent AI-assisted customer-communication platforms can influence sector valuations.MarketBeat as of 05/29/2026

The Trade Desk, which operates a larger-scale advertising-technology platform, last traded at USD 21.11 according to a 05/29/2026 snapshot, illustrating the wide dispersion in absolute share prices and market capitalizations across digital-advertising and analytics names that investors may use as broader reference points when assessing Marchex.Benzinga as of 05/29/2026

Read more

Additional news and developments on the stock can be explored via the linked overview pages.

More news on this stockInvestor relations

Sentiment and reactions on Marchex Inc

With the Archenia merger and shareholder investigation in focus, online discussions around Marchex often revolve around deal valuation, integration prospects and the potential impact on the company’s role in the U.S. marketing-technology landscape.

YouTubeXTikTokInstagram

Conclusion

Marchex shares on Nasdaq are currently trading close to USD 1.60 as U.S. investors evaluate the proposed Archenia merger and the implications of freshly announced shareholder-rights investigations. The comparison with peers in adjacent marketing-technology and conversational-analytics niches underlines how deal outcomes and sector sentiment could shape how the market values Marchex over the coming months, without changing the company’s underlying focus on conversation analytics and call-tracking solutions.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.

Disclaimer zu unseren Artikeln: Keine Anlageberatung, keine Kauf oder Verkaufsempfehlung. Angaben zu Kursen, Unternehmen und Märkten ohne Gewähr; Änderungen jederzeit möglich. Börsengeschäfte können zu hohen Verlusten führen. Unsere Beiträge werden ganz oder teilweise automatisiert mit Unterstützung von AI erstellt und geprüft.

en | US56624R1086 | MCHX | boerse | 69474970 | bgmi